AuerbachR. Angiogenesis-inducing factors: a review. In: PickE, LandyM, eds. Lymphokines. New York: Academic Press, 1981:69–88.
10.
GambleJR, MatthiasU, MeyerG. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol1993;121:921–43.
11.
KonerdingMA, VanAckernC, SteinbergF, StrefferC. Combined morphological approaches in the study of network formation in tumor angiogenesis. Angiogenesis: key principles. Basel: Birkhauser Verlag, 1992:40–58.
BrooksPC, MontgomeryAM, RosenfeldM, ReisfeldRA, HuT, KlierG, ChereshDA. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell1994;79(7):1157–64.
14.
LusterAD, GreenbergSM, LederP. The IP-10 chemokine binds to a specific cell surface heparan sulfate shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med1995;182:219–32.
15.
ReF, ZanettiA, SironiM, PolentaruttiN, LanfranconeL, DejanaE, ColottaF. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol1994;127:537–46.
HanahanD, FolkmanJ. Pattens and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell1996;86:356–64.
18.
RogeljS, KlagsbrunM, AtzmonR, KurokawaM, HaimovitzA, FuksZ, VlodavskyI. Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells. J Cell Biol1989;109(2):823–31.
19.
O'ReillyMS, HolmgrenL, ShingY, ChenC, RosenthalRA, MosesM, LaneWS, CaoY, SageEH, FolkmanJ. Angiostatin: a novel angiogenesis inhibitor that mediates suppression of metastases by a Lewis lung carcinoma. Cell1994;79(2):315–28.
StrieterRM, LukacsNW, StandifordTJ, KunkelSL. Cytokines and lung inflammation. Thorax1993;48:765–9.
23.
BaggioliniM, WalzA, KunkelSL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest1989;84:1045–9.
24.
BaggioliniM, DewaldB, WalzA. Interleukin-8 and related chemotactic cytokines. In: GallinJI, GoldsteinIM, SnydermanR, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, Ltd., 1992:247–63.
25.
MatsushimaK, OppenheimJJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine1989;1:2–13.
26.
MillerMD, KrangelMS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol1992;12:17–46.
27.
TaubDD, OppenheimJJ. Chemokines, inflammation and immune system. Ther Immunol1994;1:229–46.
28.
FarberJM. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol1997;61(3):246–57.
29.
RollinsBJ. Chemokines. Blood1997;90:909–28.
30.
BleulCC, FarzanM, ChoeH, ParolinC, Clark-LewisI, SodroskiJ, SpringerTA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature1996;382:829–33.
31.
OberlinE, AmaraA, BachelerieF, BessiaC, VirelizierJ-L, Arenzana-SeisdedosF, SchwartzO, HeardJ-M, Clark-LewisI, LeglerDF, LoetscherM, BaggioliniM, MoserB. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature1996;382:833–5.
32.
TashiroK, TadaH, HeilkerR, ShirozuM, NakanoT, HonjoT. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science1993;261:600–3.
33.
ShirozuM, NakanoT, InazawaJ, TashiroK, TadaH, ShinoharaT, HonjoT. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF-1) gene. Genomics1995;28:495–500.
34.
StrieterRM, PolveriniPJ, KunkelSL, ArenbergDA, BurdickMD, KasperJ, DzuibaJ, Van DammeJ, WalzA, MarriottD, ChanS, RoczniakS, ShanafeltA. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem1995;270(45):27348–57.
35.
WalzA, BaggioliniM. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. Exp Med1990;171:449–54.
36.
TaylorS, FolkmanJ. Protomine is an inhibitor of angiogenesis. Nature1982;297:307–12.
37.
MaioneTE, GrayGS, PetroJ, HuntAJ, DonnerAL, BauerSI, CarsonHF, SharpeRJ. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science1990;247(4938):77–9.
38.
MaioneTE, GrayGS, HuntAJ, SharpeRJ. Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res1991;51(8):2077–83.
39.
HansellP, MaioneTE, BorgstromP. Selective binding of platelet factor 4 to regions of active angiogenesis in vivo. Am J Physiol1995;269(3 Pt 2):H829–36.
40.
SharpeRJ, ByersHR, ScottCF, BauerSI, MaioneTE. Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst1990;82(10):848–53.
41.
StrieterRM, KunkelSL, ElnerVM, MartonylCL, KochAE, PolveriniPJ, ElnerSG. Interleukin-8: A corneal factor that induces neovascularization. Am J Pathol1992;141:1279–84.
42.
KochAE, PolveriniPJ, KunkelSL, HarlowLA, DiPietroLA, ElnerVM, ElnerSG, StrieterRM. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science1992; 258:1798–801.
43.
StrieterRM, KunkelSL, ArenbergDA, BurdickMD, PolveriniPJ. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun1995;210(1):51–7.
44.
ArenbergDA, PolveriniPJ, KunkelSL, ShanafeltA, StrieterRM. In vitro and in vivo systems to assess the role of CXC chemokines in the regulation of angiogenesis. Meth Enzymol1997;190–220.
45.
BouckN. Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells1990;2:179–85.
46.
BouckN. Angiogenesis: a mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis. Cancer Treat Res1992;63:359–71.
47.
FolkmanJ, WatsonK, IngberD, HanahanD. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature1989;339:58–61.
48.
MaioranaA, GullinoPM. Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. Cancer Res1978;38:4409–14.
49.
HerlynM, ClarkWH, RodeckU, ManciatiML, JambrosicJ, KoprowskiH. Biology of tumor progression in human melanocytes. Lab Invest1987;56:461–74.
50.
WeidnerN. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol1995;147(1):9–19.
51.
WeidnerN, SempleJP, WelchWR, FolkmanJ. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Eng J Med1991;324:1–8.
52.
WeidnerN, CarrollPR, FlaxJ, BlumenfeldW, FolkmanJ. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol1993;143:401–9.
53.
MacchiariniP, FontaniniG, HardinMJ, SquartiniF, AngelettiCA. Relation of neovascularization to metastasis of nonsmall cell lung cancer. Lancet1992;340:145–46.
54.
FolkmanJ. Clinical applications of research on angiogenesis. N Eng J Med1995;333(26):1757–63.
55.
EisensteinR, KuettnerKE, NeopolitanC, SobelLW, SorgenteN. The resistance of certain tissues to invasion III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am J Pathol1975;81:337–47.
56.
SmithDR, PolveriniPJ, KunkelSL, OrringerMB, WhyteRI, BurdickMD, WilkeCA, StrieterRM. Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med1994;179:1409–15.
57.
ArenbergDA, KunkelSL, PolveriniPJ, GlassM, BurdickMD, StrieterRM. Inhibition of interleukin-8 reduces tumorigenesis of human nonsmall cell lung cancer in SCID mice. J Clin Invest1996;97(12):2792–802.
58.
LuanJ, Shattuck-BrandtR, HaghnegahdarH, OwenJ, StrieterRM, BurdickM, NirodiC, BeauchampD, Newsom-JohnsonK, RichmondA. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leuk Biol1997;62(5):588–97.
59.
KitadaiY, HarumaK, SumiiK, YamamotoS, UeT, YokozakiH, YasuiW, OhmotoY, KajiyamaG, FidlerIJ, TaharaE. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Path1998;152(1):93–100.
60.
ArenbergDA, KunkelSL, PolveriniPJ, MorrisSB, BurdickMD, GlassM, TaubDT, IannetoniMD, WhyteRI, StrieterRM. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human nonsmall cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med1996;184(3):981–92.
PeaoMND, AguasAP, DeSaCM, GrandeNR. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec1994;238:57–67.
63.
KeaneM, ArenbergD, LynchJPIII, WhyteR, IannetoniM, BurdickM, WilkeC, MorrisS, GlassM, DiGioviveB, KunkelS, StrieterRM. The CXC chemokines, IL-8, and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol1997;159:1437–43.
64.
StoutAJ, GresserI, ThompsonWD. Inhibition of wound healing in mice by local interferon alpha/beta injection. Int J Exp Pathol1993;74(1):79–85.
65.
HydeDM, HendersonTS, GiriSN, TylerNK, StovallMY. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res. 1988;14:687–95.
66.
LoetscherM, GerberB, LoetscherP, JonesSA, PialiL, Clark-LewisI, BaggioliniM, MoserB. Chemokine receptor specific for IP10 and MIG: structure, function, and expression in activated T-lymphocytes. J Exp Med1996;184(3):963–9.
67.
PremackBA, SchallTJ. Chemokine receptors: gateways to inflammation and infection. Nature Med1996;2:1174–8.
68.
SchönbeckU, BrandtE, PetersenF, FladH, LoppnowH. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol1995;154:2375–83.
69.
LeeJ, HorukR, RiceGC, BennettGL, CameratoT, WoodWI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem1992;267:16283–7.
70.
HadleyTJ, LuZ, WasniowskaK, PeiperSC, HesselgesserJ, HorukR. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy bloodgroup antigen. J Clin Invest1994;94:985–91.
71.
NeoteK, DarbonneW, OgezJ, HorukR, SchallT. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem1993;268:12247–53.
72.
NanneyLB, MuellerSG, BuenoR, PeiperSC, RichmondA. Distributions of melanoma growth stimulatory activity or growth-related gene and the interleukin-8 receptor type B in human wound repair. Am J Pathol1995;147(5):1248–60.
73.
ArvanitakisL, Geras-RaakaE, VarmaA, GershengornMC, CesarmanE. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation [see comments]. Nature1997;385(6614):347–50.
74.
BaisC, SantomassoB, CosoO, ArvanitakisL, RaakaEG, GutkindJS, AschAS, CesarmanE, GerhengornMC, MesriEA. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature1998;391:86–9.
75.
BoshoffC. Coupling herpesvirus to angiogenesis. Nature1998;391:24–5.
MoorePS, BoshoffC, WeissRA, ChangY. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science1996;274(5293):1739–44.
78.
ChangY, CesarmanE, PessinMS, LeeF, CulpepperJ, KnowlesDM, MoorePS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposis's sarcoma. Science1994;266:1865–9.
79.
CesarmanE, ChangY, MoorePS, SaidJW, KnowlesDM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity B-cell lymphoma. N Engl J Med1995;335:1186–91.
RussoJJ, BohenzkyRA, ChienMC, ChenJ, YanM, MaddalenaD, ParryJP, PeruzziD, EdelmanIS, ChangY, MoorePS. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad Sci USA1997;93:14862–7.
82.
RenneR, ZhongW, HerndierB, McGrathM, AbbeyN, KedesD, GanemD. Lytic growth of Kaposi's sarcoma associated herpesvirus (HHV-8) in culture. Nat Med1996;2(3):342–6.
83.
MesriEA, CesarmanE, ArvanitakesL., FafiiS, MooreMA, PosnettDN, KnowlesDM, AschAS. Human herpesvirus-8/Kaposi's sarcoma-acssociated herpesvirus is a new transmissible virus that infects B. cells. J Exp Med1996;183:2385–90.
84.
YasumotoK, OkamotoS, MukaidaN, MurakamiS, MaiM, MatsushimaK. Tumor necrosis factor a and interferon y synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NFKB-like binding sites on the interleukin 8 gene. J Biol Chem1992;267:22506–11.